Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2008, Article ID 727505, 5 pages
http://dx.doi.org/10.1155/2008/727505
Research Article

Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates

1Infectious Disease Epidemiology, Prevention and Control Division, Minnesota Department of Health, 625 Robert Street North, P.O. Box 64975, Saint Paul, MN 55164, USA
2Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
3Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
4Streptococcus Laboratory, Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, USA
5Pediatrics and Laboratory Medicine and Pathology, Clinical Microbiology Laboratory, University of Minnesota Medical School, 420 Delaware Street SE Minneapolis, MN 55455, USA
6Public Health Laboratory Division, Minnesota Department of Health, 601 Robert Street North, P.O. Box 64899, Saint Paul, MN 55164, USA
7Public Health Division, Oregon Department of Human Services, 800 NE Oregon Street, Portland, OR 97232, USA
8Atlanta Veterans Affairs Medical Center, Emory University School of Medicine, 1670 Clairmont Rd, Station 151 Decatur, GA 30033, USA
9Wadsworth Center, New York State Department of Health, 120 New Scotland Avenue, Albany, NY 12208, USA

Received 10 June 2008; Accepted 5 December 2008

Academic Editor: Reginald Sauve

Copyright © 2008 Mei L. Castor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. J. Schrag, S. Zywicki, M. M. Farley et al., “Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis,” The New England Journal of Medicine, vol. 342, no. 1, pp. 15–20, 2000. View at Publisher · View at Google Scholar
  2. S. Schrag, R. Gorwitz, K. Fultz-Butts, and A. Schuchat, “Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC,” MMWR Recommendations and Reports, vol. 51, no. RR-11, pp. 1–22, 2002. View at Google Scholar
  3. M. Fernandez, M. E. Hickman, and C. J. Baker, “Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 6, pp. 1517–1519, 1998. View at Google Scholar
  4. F.-Y. C. Lin, P. H. Azimi, L. E. Weisman et al., “Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995–1998,” Clinical Infectious Diseases, vol. 31, no. 1, pp. 76–79, 2000. View at Publisher · View at Google Scholar
  5. M. D. Pearlman, C. L. Pierson, and R. G. Faix, “Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin,” Obstetrics & Gynecology, vol. 92, no. 2, pp. 258–261, 1998. View at Publisher · View at Google Scholar
  6. A. S. Arisoy, B. Altinişik, Ö. Tünger, S. Kurutepe, and Ç. Ispahi, “Maternal carriage and antimicrobial resistance profile of group B Streptococcus,” Infection, vol. 31, no. 4, pp. 244–246, 2003. View at Publisher · View at Google Scholar
  7. S. D. Manning, B. Foxman, C. L. Pierson, P. Tallman, C. J. Baker, and M. D. Pearlman, “Correlates of antibiotic-resistant group B Streptococcus isolated from pregnant women,” Obstetrics & Gynecology, vol. 101, no. 1, pp. 74–79, 2003. View at Publisher · View at Google Scholar
  8. D. J. Biedenbach, J. M. Stephen, and R. N. Jones, “Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program—North America, 2001,” Diagnostic Microbiology and Infectious Disease, vol. 46, no. 4, pp. 291–294, 2003. View at Publisher · View at Google Scholar
  9. R. Leclercq, “Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications,” Clinical Infectious Diseases, vol. 34, no. 4, pp. 482–492, 2002. View at Publisher · View at Google Scholar
  10. NCCLS, “Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement,” CLSI/NCCLS Document M100-S15, Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2005. View at Google Scholar
  11. H. M. Blumberg, D. S. Stephens, M. Modansky et al., “Invasive group B streptococcal disease: the emergence of serotype V,” The Journal of Infectious Diseases, vol. 173, no. 2, pp. 365–373, 1996. View at Google Scholar
  12. A. Schuchat, T. Hilger, E. Zell et al., “Active bacterial core surveillance of the emerging infections program network,” Emerging Infectious Diseases, vol. 7, no. 1, pp. 92–99, 2001. View at Google Scholar
  13. J. Sutcliffe, T. Grebe, A. Tait-Kamradt, and L. Wondrack, “Detection of erythromycin-resistant determinants by PCR,” Antimicrobial Agents and Chemotherapy, vol. 40, no. 11, pp. 2562–2566, 1996. View at Google Scholar
  14. M. C. Roberts, J. Sutcliffe, P. Courvalin, L. B. Jensen, J. Rood, and H. Seppala, “Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants,” Antimicrobial Agents and Chemotherapy, vol. 43, no. 12, pp. 2823–2830, 1999. View at Google Scholar
  15. M. Pearlman, “Prevention of early-onset group B streptococcal disease in newborns,” Obstetrics & Gynecology, vol. 102, no. 2, pp. 414–415, 2003. View at Publisher · View at Google Scholar